Raya Therapeutic Inc., (Raya) a mission─driven company focused on the treatment of ALS and other neurodegenerative diseases, announced supportive...
Vous n'êtes pas connecté
ALS Trial Navigator Offers People Living with ALS an Easy Way to Search Eligible Research Studies REDLANDS, Calif. — The ALS Therapy Development Institute ( ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator. […]
Raya Therapeutic Inc., (Raya) a mission─driven company focused on the treatment of ALS and other neurodegenerative diseases, announced supportive...
In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as well as the neurological diseases...
WEDNESDAY, June 26, 2024 -- For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the...